1001020-17-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Tert-Butyl-1H-Pyrazol-4-carbaldehyde is used as a building block for the synthesis of various pharmaceuticals, leveraging its chemical reactivity and structural features to create new drug molecules. Its presence in the synthesis process is crucial for developing compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Tert-Butyl-1H-Pyrazol-4-carbaldehyde serves as an intermediate in the production of agrochemicals. Its role is pivotal in the creation of compounds that can be used in pest control and crop protection, contributing to the development of effective and targeted agrochemical products.
Used in Organic Chemistry Research:
3-Tert-Butyl-1H-Pyrazol-4-carbaldehyde is utilized as a reagent in organic chemistry, facilitating a range of chemical reactions. Its pyrazole ring and aldehyde group make it a key component in the preparation of heterocyclic compounds, which are important in various chemical and pharmaceutical applications.
Used in Chemical Synthesis:
3-Tert-Butyl-1H-Pyrazol-4-carbaldehyde is employed as an intermediate in the synthesis of a wide array of organic compounds. Its versatility in organic reactions allows for the creation of diverse chemical entities, expanding the scope of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1001020-17-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,0,2 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1001020-17:
(9*1)+(8*0)+(7*0)+(6*1)+(5*0)+(4*2)+(3*0)+(2*1)+(1*7)=32
32 % 10 = 2
So 1001020-17-2 is a valid CAS Registry Number.
1001020-17-2Relevant articles and documents
PYRAZOLEALKANAMIDE SUBSTITUTED THIOPHENES AS AMPA POTENTIATORS
-
Page/Page column 64-65, (2008/06/13)
The present invention relates to a heterocyclic derivative according to Formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceuti